Myles Greenberg - President and CEO @ InCarda Therapeutics

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title President and CEO
Primary Organization
InCarda Therapeutics

Location Salt Lake City, Utah, United States
Regions Western US
Gender Male

Investor Type
obfuscated
obfuscation

Facebook View on Facebook
LinkedIn View on LinkedIn
X (Twitter) View on X

Myles Greenberg is based out of Salt Lake City, Utah and is the President and CEO of InCarda Therapeutics. Myles previously worked at Alucent Biomedical, Inc. as a President and CEO. Myles Greenberg attended Harvard Business School.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Mevion Medical Systems	CHL Medical Partners	No	Private Equity Round - Mevion Medical Systems	obfuscated obfuscation
obfuscated obfuscation	Vascular Pathways	CHL Medical Partners	—	Debt Financing - Vascular Pathways	obfuscated obfuscation
obfuscated obfuscation	Mevion Medical Systems	CHL Medical Partners	—	Private Equity Round - Mevion Medical Systems	obfuscated obfuscation
obfuscated obfuscation	Ambra Health	CHL Medical Partners	Yes	Series B - Ambra Health	obfuscated obfuscation
obfuscated obfuscation	Mevion Medical Systems	CHL Medical Partners	No	Venture Round - Mevion Medical Systems	obfuscated obfuscation
obfuscated obfuscation	Ambra Health	CHL Medical Partners	—	Series A - Ambra Health	obfuscated obfuscation
obfuscated obfuscation	Vascular Pathways	CHL Medical Partners	Yes	Series B - Vascular Pathways	obfuscated obfuscation
obfuscated obfuscation	Vertos Medical	CHL Medical Partners	No	Series D - Vertos Medical	obfuscated obfuscation
obfuscated obfuscation	Mevion Medical Systems	CHL Medical Partners	—	Venture Round - Mevion Medical Systems	obfuscated obfuscation
obfuscated obfuscation	Vertos Medical	CHL Medical Partners	Yes	Series C - Vertos Medical	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Myles Greenberg

has

current jobs including

President and CEO

InCarda Therapeutics

Executive Partner

Leavitt Equity Partners

, and

Co-Founder & Exec Chair

Focused Therapeutics

. Additionally,

Myles Greenberg

has had

past jobs including

Partner

HealthInvest Equity Partners

InCarda Therapeutics President and CEONov 2024
Leavitt Equity Partners Executive PartnerJan 2024
Focused Therapeutics Co-Founder & Exec ChairDec 2021
University of Utah - David Eccles School of Business Adjunct Asst. Professor & Entrepreneur In ResidenceApr 2017
Alucent Biomedical President & CEO

Organization Name	Title At Company	Start Date	End Date
HealthInvest Equity Partners	Partner	2004	2016
CHL Medical Partners	Partner	2004	2016
Syntonix Pharmaceuticals	Team Member	—	—
Pappas Ventures	Senior Principal (A.M. Pappas & Associates)	—	—
NuVasive	Team Member	—	—
LipoScience	Team Member	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Myles Greenberg

holds

board and advisor roles including

Chairman

BioUtah

Member, Board of Directors and Founding Investor

CareWell Urgent Care

, and

Director

Dynogen Pharmaceuticals

BioUtah ChairmanJan 2019
CareWell Urgent Care Member, Board of Directors and Founding InvestorMar 2012
Dynogen Pharmaceuticals Director
Cantex Pharmaceuticals Board Positions

Organization Name	Title At Company	Start Date	End Date
Vertos Medical	Board of Directors	2008	Mar 2016
Mevion Medical Systems	Member, Board of Directors	Mar 2009	Dec 2015
Millennium Pharmacy Systems	Member, Board of Directors and Lead Investor	2005	Sep 2014
Oriel Therapeutics	Board Positions	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Western US Therapeutics Companies	14,987
Health Care Late Stage Companies With Less Than $500M in Revenue	26,603
Health Care Late Stage Companies With Fewer Than 1000 Employees	27,011
Western US Late Stage Companies With More Than $100M in Revenue	45,181
Health Care Late Stage Companies With More Than $10M in Revenue	39,098
United States Health Care Companies with Late Stage Venture Funding	38,446
United States Startups Founded in 2009	56,975
Biotechnology Late Stage Companies With More Than $10M in Revenue	32,828
Therapeutics Companies With More Than $100M in Revenue	42,344
Health Diagnostics Startups	30,121